Jazz Pharmaceuticals
JAZZ
JAZZ
454 hedge funds and large institutions have $6.13B invested in Jazz Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 159 increasing their positions, 164 reducing their positions, and 83 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
12% less capital invested
Capital invested by funds: $6.96B → $6.13B (-$830M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
25% less first-time investments, than exits
New positions opened: 62 | Existing positions closed: 83
Holders
454
Holding in Top 10
6
Calls
$27.7M
Puts
$17.2M
Top Buyers
| 1 | +$110M | |
| 2 | +$67.8M | |
| 3 | +$65.1M | |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$58M |
| 5 |
BG
Baupost Group
Boston,
Massachusetts
|
+$48.4M |
Top Sellers
| 1 | -$102M | |
| 2 | -$67.7M | |
| 3 | -$48.9M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$34M |
| 5 |
Morgan Stanley
New York
|
-$26.8M |